Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies
- 1 August 2006
- journal article
- review article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 65 (8) , 983-989
- https://doi.org/10.1136/ard.2005.043257
Abstract
Understanding of the natural history and basic biology of hepatitis B virus (HBV) has increased greatly in recent years. In view of this, the following are reviewed here: (a) recent advances in HBV biology pertinent to the rheumatic disease population; (b) the risks of HBV reactivation in patients with rheumatic disease undergoing immunosuppression; and (c) potential strategies to manage these risks.Keywords
This publication has 54 references indexed in Scilit:
- Guidelines for the management of rheumatoid arthritis: 2002 UpdateArthritis & Rheumatism, 2002
- Complex HBV populations with mutations in core promoter, C gene, and pre-S region are associated with development of cirrhosis in long-term renal transplant recipientsHepatology, 2002
- A concise update on the status of liver transplantation for hepatitis B virus: The challenges in 2002Liver Transplantation, 2002
- Chronic hepatitis BHepatology, 2001
- Hepatitis B virus reactivation during cytotoxic chemotherapy-enhanced viral replication precedes overt hepatitis.2001
- Hepatitis B e antigen-negative chronic hepatitis BHepatology, 2001
- Acute flares in chronic hepatitis B: The natural and unnatural history of an immunologically mediated liver diseaseGastroenterology, 2001
- Development of fulminant hepatitis B (precore variant mutant type) after the discontinuation of low-dose methotrexate therapy in a rheumatoid arthritis patientArthritis & Rheumatism, 2001
- Lamivudine allows completion of chemotherapy in lymphoma patients with hepatitis B reactivationBritish Journal of Haematology, 2000
- ACUTE LIVER DECOMPENSATION ON WITHDRAWAL OF CYTO-TOXIC CHEMOTHERAPY AND IMMUNOSUPPRESSIVE THERAPY IN HEPATITIS-B CARRIERS1989